Atlas Trials

Clonal Hematopoiesis of Immunological Significance

Clinical trial NCT05969821 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05969821
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Immune System DiseasesAutoimmune DiseasesInflammationAutoinflammatory DiseasesVexas SyndromeHematopoiesis ClonalClonal Hematopoiesis of Indeterminate PotentialHematologic DiseasesMyelodysplastic-Myeloproliferative DiseasesLeukemia Myelomonocytic ChronicMyelodysplastic SyndromesMyeloproliferative Disorders
Start date
2026-04-01
Primary completion
2036-04-01
Enrollment
5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.